
APIs are allowed to be imported to regulated markets, offering pharmaceutical companies greater sourcing flexibility and superior supplier options. The benefits are accompanied, however, with many compliance requirements. Companies with a focus on supplier qualification, documentation verification, GMP compliance and transparency in the supply chain are more likely to avoid more expensive issues related to regulatory compliance. Compliance is no longer just a regulatory matter but it also constitutes a competitive advantage to ensure quality of product, continuity of business and access to the market in the pharmaceutical industry.
More Info: https://chemdmart.com/blog/how-to-mitigate-compliance-risks-when-importing-apis-into-regulated-markets
11 total views, 2 today